Distribution and evolution of acute interventional ischemic stroke treatment in Germany from 2010 to 2016

GBD 2015 Neurological Disorders Collaborator Group. (2017). Global, regional, and national burden of neurological disorders during 1990–2015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet Neurology, 16, 877–897.

Broderick, J. P., Palesch, Y. Y., Demchuk, A. M., et al. (2013). Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. The New England Journal of Medicine, 368, 893–903.

Ciccone, A., Valvassori, L., Nichelatti, M., et al. (2013). The New England Journal of Medicine, 368, 904–913.

Kidwell, C. S., Jahan, R., Gornbein, J., et al. (2013). A trial of imaging selection and endovascular treatment for ischemic stroke. The New England Journal of Medicine, 368, 914–923.

Berkhemer, O., Fransen, P., Beumer, D., et al. (2015). A randomized trial of intraarterial treatment for acute ischemic stroke. The New England Journal of Medicine, 372, 11–20.

Campbell, B., Mitchell, P., Kleinig, T., et al. (2015). Endovascular therapy for ischemic stroke with perfusion-imaging selection. The New England Journal of Medicine, 372, 1009–1018.

Goyal, M., Demchuk, A., Menon, B., et al. (2015). Randomized assessment of rapid endovascular treatment of ischemic stroke. The New England Journal of Medicine, 372, 1019–1030.

Saver, J. L., Goyal, M., Bonafe, A., et al. (2015). Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. The New England Journal of Medicine, 372, 2285–2295.

Jovin, T., Chamorro, A., Cobo, E., et al. (2015). Thrombectomy within 8 hours after symptom onset in ischemic stroke. The New England Journal of Medicine, 372, 2296–2306.

Goyal, M., Menon, B. K., van Zwam, W. H., et al. (2016). Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet, 387, 1723–1731.

Stroke Unit Trialists’Collaboration. (2013). Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews, 9, CD000197.

Hacke, W., Kaste, M., Bluhmki, E., et al. (2008). And the ECASS investigators. Thrombolysis with alteplase 3 to 4·5 hours after acute ischemic stroke. The New England Journal of Medicine, 359, 1317–1329.

Emberson, J., Lees, K. R., Lyden, P., et al. (2014). Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischemic stroke: A meta-analysis of individual patint data from randomized trials. Lancet, 384, 1929–1935.

Chia, N. H., Leyden, J. M., Newbury, J., Jannes, J., & Kleinig, T. J. (2016). Determining the number of ischemic strokes potentially eligible for endovascular thrombectomy: A population-based study. Stroke, 47, 1377–1380.

McMeekin, P., White, P., James, M. A., Price, C. I., Flynn, D., & Ford, G. A. (2017). Estimating the number of UK stroke patients eligible for endovascular thrombectomy. European Stroke Journal, 2, 319–326.

Eyding, J., Grönheit, W., Rother, S., et al. (2013). Optimised rate of specific, revascularising therapies in acute stroke – What is the aim? Considerations from the experience of a tertiary Centre. Fortschritte der Neurologie-Psychiatrie, 81, 69–74.

Weber, R., Reimann, G., Weimar, C., et al. (2016). Outcome and periprocedural time management in referred versus directly admitted stroke patients treated with thrombectomy. Therapeutic Advances in Neurological Disorders, 9, 79–84.

Froehler, M. T., Saver, J. L., Zaidat, O. O., et al. (2017). Interhospital transfer before thrombectomy is associated with delayed treatment and worse outcome in the STRATIS registry (systematic evaluation of patients treated with Neurothrombectomy devices for acute ischemic stroke). Circulation, 136, 2311–2321.

Saver, J. L., Goyal, M., van der Lugt, A., et al. (2016). Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: A meta-analysis. JAMA, 316, 1279–1288.

Eyding, J., Weimar, C., Brassel, F., et al. (2012). The “neurovascular net Ruhr”. Concept and implementation of a transregional network to optimize neurovascular treatment of acute stroke patients in the Ruhr district. Akt Neurol, 39, 404–411.

Wei, D., Oxley, T. J., Nistal, D. A., et al. (2017). Mobile interventional stroke teams Lead to faster treatment times for Thrombectomy in large vessel occlusion. Stroke, 48, 3295–3300.

Weber, R., Nordmeyer, H., Hadisurya, J., et al. (2017). Comparison of outcome and interventional complication rate in patients with acute stroke treated with mechanical thrombectomy with and without bridging thrombolysis. Journal Neurointerv Surgery, 9, 229–233.

Coutinho, J. M., Liebeskind, D. S., Slater, L. A., et al. (2017). Combined intravenous thrombolysis and thrombectomy vs. thrombectomy alone for acute ischemic stroke: A pooled analysis of the SWIFT and STAR studies. JAMA Neurology, 74, 268–274.

Hassan, A. E., Chaudhry, S. A., Grigoryan, M., Tekle, W. G., & Qureshi, A. I. (2012). National trends in utilization and outcomes of endovascular treatment of acute ischemic stroke patients in the mechanical thrombectomy era. Stroke, 43, 3012–3017.

Villwock, M. R., Padalino, D. J., & Deshaies, E. M. (2016). Trends in mortality following mechanical thrombectomy for the treatment of acute ischemic stroke in the USA. Journal Neurointerv Surgery, 8, 457–460.

Kim, B. J., Park, J. M., Kang, K., et al. (2015). Case characteristics, hyperacute treatment, and outcome information from the clinical research center for stroke-fifth division registry in South Korea. Journal Stroke, 17, 38–53.

De Sousa, D. A., von Martial, R., Abilleira, S., Gattringer, T., Kobayashi, A., Gallofre, M., Fazekas, F., Szikora, I., Feigin, V., Caso, V., Fischer, U., & on behalf of the ESO ESMINT EAN SAFE Survey on Stroke Care collaborators. (2018). Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries. European Stroke Journal https://doi.org/10.1177/2396987318786023 .